Make informed anti thrombotic therapy decisions for AF patients.
advertisement
| Name | AnticoagEvaluator |
|---|---|
| Version | 4.7 |
| Update | Aug 23, 2024 |
| Size | 5 MB |
| Category | Medical |
| Installs | 10K+ |
| Developer | American College of Cardiology Foundation |
| Android OS | Android 7.0+ |
| Google Play ID | org.acc.AnticoagEvaluatorV2 |
AnticoagEvaluator · Screenshots
AnticoagEvaluator · Description
Make well-informed decisions on anti thrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for anti thrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for anti thrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
